Acute Lymphoblastic Leukemia Around the Practice ASCO Gastrointestinal Cancers Symposium HER2-Positive Breast Cancer Non-Small Cell Lung Cancer (NSCLC)Prostate Cancer

Acute Lymphoblastic LeukemiaAround the PracticeASCO Gastrointestinal Cancers SymposiumHER2-Positive Breast CancerNon-Small Cell Lung Cancer (NSCLC)Prostate Cancer

Clinical

View More Brain Cancer Breast Cancer Colorectal Cancer Gastrointestinal Cancer Genitourinary Cancer Gynecologic Cancer Hematology Leukemia Lung Cancer Lymphoma Pediatric Cancers Skin Cancer

Brain CancerBreast CancerColorectal CancerGastrointestinal CancerGenitourinary CancerGynecologic CancerHematologyLeukemiaLung CancerLymphomaPediatric CancersSkin Cancer

News

All News NP/PA Practice Management Technology

All NewsNP/PAPractice ManagementTechnology

Media

Around the Practice Clinical Consult Enduring Webinars Expert Interviews K-Cast Medical World News Podcasts Readout 360 Tumor Board Series

Around the PracticeClinical ConsultEnduring WebinarsExpert InterviewsK-CastMedical World NewsPodcastsReadout 360Tumor Board Series

Conferences

Publications

About Oncology Journal Oncology Journal

About Oncology JournalOncology Journal

Events

Live Events Virtual Events

Live EventsVirtual Events

CME/CE

Resources

Image IQ Polls Quizzes Slideshows Sponsored Toolkits

Image IQPollsQuizzesSlideshowsSponsoredToolkits

eNewsletter Print Subscription

eNewsletterPrint Subscription

CureToday.com
OncLive.com
TargetedOnc.com
Contact
Terms and Conditions
Privacy
Do Not Sell My Personal Information

Spotlight

Acute Lymphoblastic Leukemia
Around the Practice
ASCO Gastrointestinal Cancers Symposium
HER2-Positive Breast Cancer
Non-Small Cell Lung Cancer (NSCLC)
Prostate Cancer

ClinicalSee All >

Brain Cancer
Breast Cancer
Colorectal Cancer
Gastrointestinal Cancer
Genitourinary Cancer
Gynecologic Cancer
Hematology
Leukemia
Lung Cancer
Lymphoma
Pediatric Cancers
Skin Cancer

CureToday.com
OncLive.com
TargetedOnc.com
Contact
Terms and Conditions
Privacy
Do Not Sell My Personal Information

Jonathan S. Batchelor | Authors

CRUCES PHARMACY

PO BOX 477

Articles

Provenge wild ride blazes trail for immunotherapy

December 06, 2010

Amidst controversy, the FDA finally approved the controversial prostate cancer therapy. Hopes are high that Provenge represents the first in a long line of effective immunotherapeutics.